A next-generation nanobody-liposome treatment slashes tumor growth by homing in on a key cancer marker, opening new doors for safer and more effective lung cancer therapy. Study: Targeting CD155 in ...

While targeted therapies have nearly doubled survival for some cancers, lung cancer continues to claim more lives than any ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells to target tumors. TIL therapy, now FDA-approved for solid tumors, shows ...

Researchers visualized ALK fusion proteins in real time. They showed that ALK inhibitors reshape flexible protein regions to ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

Rebecca Siegel highlights alarming cancer disparities among American Indian, Alaska Native, and Black populations, ...

This transcript has been edited for clarity. Jacob Sands, MD: Hello. I'm Dr Jacob Sands, a thoracic medical oncologist at the Dana-Farber Cancer Institute. Welcome to Medscape's InDiscussion series on ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

“Lung cancer, though common and serious, still has many misconceptions,” says Ian Bostock, MD, a thoracic surgeon at Miami Cancer Institute in Florida. “Clearing these myths helps patients and ...